Staying out or going in? The interplay between type 3 and type 5 secretion systems in adhesion and invasion of enterobacterial pathogens by Whelan, R et al.
 International Journal of 
Molecular Sciences
Review
Staying out or Going in? The Interplay between Type
3 and Type 5 Secretion Systems in Adhesion and
Invasion of Enterobacterial Pathogens
Rachel Whelan , Gareth McVicker and Jack C. Leo *
Antimicrobial Resistance, Omics and Microbiota Group, Department of Biosciences, Nottingham Trent
University, Nottingham NG1 4FQ, UK; rachel.whelan2015@my.ntu.ac.uk (R.W.);
gareth.mcvicker@ntu.ac.uk (G.M.)
* Correspondence: jack.leo@ntu.ac.uk; Tel.: +44-115-848-3482
Received: 12 May 2020; Accepted: 5 June 2020; Published: 8 June 2020


Abstract: Enteric pathogens rely on a variety of toxins, adhesins and other virulence factors to cause
infections. Some of the best studied pathogens belong to the Enterobacterales order; these include
enteropathogenic and enterohemorrhagic Escherichia coli, Shigella spp., and the enteropathogenic
Yersiniae. The pathogenesis of these organisms involves two different secretion systems, a type 3
secretion system (T3SS) and type 5 secretion systems (T5SSs). The T3SS forms a syringe-like structure
spanning both bacterial membranes and the host cell plasma membrane that translocates toxic effector
proteins into the cytoplasm of the host cell. T5SSs are also known as autotransporters, and they export
part of their own polypeptide to the bacterial cell surface where it exerts its function, such as adhesion
to host cell receptors. During infection with these enteropathogens, the T3SS and T5SS act in concert to
bring about rearrangements of the host cell cytoskeleton, either to invade the cell, confer intracellular
motility, evade phagocytosis or produce novel structures to shelter the bacteria. Thus, in these
bacteria, not only the T3SS effectors but also T5SS proteins could be considered “cytoskeletoxins” that
bring about profound alterations in host cell cytoskeletal dynamics and lead to pathogenic outcomes.
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1. Introduction
The Gram-negative families Enterobacteriaceae and Yersiniaceae are two well-studied groups of
microorganisms that form part of the order Enterobacterales [1]. Both families include pathogens that
are able to cause intestinal and extraintestinal infection in the human host. Intestinal infection often
leads to moderate to severe diarrhoea through alteration and/or disruption of the intestinal epithelium,
which in some cases results in death, and is particularly pronounced amongst children under five years
old and individuals in low-income regions.
Diarrhoeagenic pathogens from genera such as Salmonella, Yersinia, Escherichia and Shigella are
a significant health burden worldwide, with diarrhoea causing over 1.6 million global deaths per
year as recently as 2016 [2]. Large-scale studies of children in developing countries confirmed
the contribution of enteropathogenic Escherichia coli (EPEC) and Shigella to severe diarrhoea and
mortality [3,4]. Shigella can be considered a form of enteroinvasive E. coli (EIEC); the two pathovars
have seemingly arisen through convergent evolution of multiple lineages after the acquisition of
horizontally acquired virulence genes [5], and so present both medical and diagnostic challenges [6–8].
Antibiotic-resistant Shigella remains a significant problem in the western world and has even found a
niche as a sexually transmitted infection [9,10]. Studies in Europe have highlighted the considerable
economic cost of Yersinia infection, which may be dramatically underreported [11,12]. Similarly,
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Shiga-toxigenic E. coli (STEC), responsible for haemolytic uremic syndrome, was previously estimated
to result in over 175,000 infections annually in the USA [13] and caused a large, multistate outbreak
in 2018 [14]. Note that, in this review, we will use the term STEC to refer to the broader class of
Shiga-toxigenic strains (including those that do not encode the locus of enterocyte effacement (LEE))
and reserve the term enterohemorrhagic E. coli (EHEC) to refer to LEE-encoding strains such as
O157:H7.
The virulence factors employed by diarrhoeagenic pathogens range from single-protein exotoxins
to complex, macromolecular assemblies anchored within the bacterial cell wall. Such virulence factors
include flagella, fimbriae (pili) and secretion systems (SSs).
2. Secretion Systems in Enterobacterial Pathogenesis
In order to interact with the external environment, bacteria must secrete proteins to the cell surface
or the external medium. In Gram-negative and other diderm bacteria such as Mycobacterium spp.,
the presence of an outer membrane poses an additional obstacle for secreting macromolecules to the
outside of the cell. Nevertheless, diderm bacteria have evolved several distinct secretion pathways
to translocate proteins across the cell envelope. Currently, there are nine “official” SSs designated
with a number (type 1 secretion, type 2 secretion, etc.) as well as the chaperone–usher pathway for
constructing pili [15]. In addition, some pathways have been described that have not (yet) been
accepted into the canon [16–18]. Enterobacteria use many of these systems to export toxins or even
to inject them directly into the host cell cytoplasm. Such injected toxins are generally referred to as
“effectors”, which are secreted by type 3 SSs (T3SSs), T4SSs and T6SSs. In addition, enterobacteria rely
on adhesins for host cell contact in order to inject effectors or to efficiently deliver extracellular toxins
to target cells. Adhesins are generally secreted by the T5SS or assembled by the chaperone–usher
pathway, or the T2SS for type IV pilus assembly [19]. In enterobacteria, the T5SS and T3SS often
act in concert to promote effector injection, typically leading to rearrangements of the cytoskeleton.
The maintenance of the host cytoskeleton plays a key role in the preservation of the cellular structure,
vesicular transport, and the highly conserved regulation of cellular permeability. However, infections
with pathogens encoding the T3SS often interfere with these essential structures [20]. Here, we review
how these two secretion systems, the T3SS and T5SS, synergize to allow bacteria to invade host cells,
escape phagocytosis, confer intracellular motility or change cellular morphology.
2.1. Type 3 Secretion Systems
2.1.1. Overview
The T3SS or “injectisome” is a complex structure that likely shares an evolutionary origin
with flagella (reviewed in [21]). It functions as a molecular syringe—an ATP and proton motive
force-dependent unfolding and secretion mechanism [22] that transports effector proteins from a
bacterial cell’s cytoplasm directly into another target cell, eukaryotic or otherwise. Both invasive and
non-invasive enteropathogens carry structurally homologous T3SSs, the primary difference between
them being the effector proteins that are delivered into the host. In diarrhoeagenic E. coli, Shigella and
Yersinia, the target cell is often part of the human intestinal epithelium, although T3SS also have an
important anti-phagocytic function that will be explored below.
Structurally, the T3SS spans both the inner and outer membrane of the Gram-negative cell
(Figure 1) and is composed of dozens of distinct proteins that have close homologues throughout the
Enterobacterales. The main structural units of the T3SS are often encoded in pathogenicity islands
and, due to the % GC content of the genes compared to genomic DNA and phylogenetic comparisons
between T3SS variants, it seems likely that such systems are primarily horizontally acquired [23].
Indeed, in Yersinia enterocolitica and Y. pseudotuberculosis, as well as in EIEC and all four Shigella species,
the T3SS required for host epithelium invasion is encoded within a pathogenicity island carried on a
virulence plasmid. T3SS-encoding plasmids vary in size from approximately 70 kb (Yersinia pYV; [24])
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to over 290 kb (EIEC pINV; [5]). Shigella pINV, at approximately 220 kb, is more similar to pINV from
EIEC in terms of gross composition and function than it is to pYV [25].
Chromosomal T3SSs often serve a different function to their plasmid-borne counterparts. In EPEC
and EHEC strains, a T3SS encoded within the chromosomal LEE provides the organism with a mechanism
of adherence that does not typically lead to host cell invasion (reviewed in [26]). Instead, the LEE T3SS
injects an effector protein, translocated intimin receptor (Tir), into the host epithelial cell in order to initiate
actin pedestal formation. The role of Tir is discussed in Section 3 below and demonstrates one way in
which T3SS and T5SS function together. The minimal “core” T3SS locus is approximately 30 kb [27].
Figure 1. Schematic of type 3 secretion systems. The major structural rings (C-ring in olive, inner/outer
membrane scaffold rings in blue) support the ATPase-containing export apparatus (orange), which is
linked via an inner rod adaptor helix to the needle filament (grey oblongs and blue circles, respectively).
Tip and gatekeeper proteins (purple, yellow, red) initially block the needle and prevent effector
translocation (left) until the complex senses host cell contact—note that SctE (IpaB) has only been
shown to play a role in blocking secretion in Shigella. Rearrangements then permit hydrophobic pore
formation (purple, green) in the eukaryotic membrane and effector secretion (right). Proteins are not
shown to scale. Adapted from [28–31].
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2.1.2. Architecture and Assembly of the T3SS
The T3SS (Figure 1) contains three major components: a basal body that is anchored within the
inner and outer membranes of the bacterial cell; a hollow needle passing through the basal body to
beyond the cell envelope; and a needle tip complex referred to as the translocon. The basal body
contains an ATP-dependent export apparatus [30] that recruits and unfolds effector proteins in order
for them to pass through the needle. The translocon acts both as a regulatory “plug” for the needle and
as a pore-forming complex, inserting a pore in the target cell membrane and initiating secretion from
the needle in response. Though it was the subject of debate for some time, in an elegant experiment
using a “blocked” T3SS needle, Dohlich and coworkers demonstrated that effector proteins do indeed
travel through the central needle of the T3SS in order to reach target cells [32]. Similarly, Radics et al.
used cryo-electron microscopy to visualize the Salmonella effector SptP as an unfolded mass within the
needle [33]. Hence, the needle/translocon does not simply act as a signal transduction mechanism for
other types of protein export [34]. However, in recent years, it has become apparent that the T3SS can
also mediate the transport of some externally added effectors into host cells [35,36].
Assembly of a T3SS and subsequent protein secretion appears to be a strictly hierarchical process
with homology across multiple species (reviewed in [30]). The basal body is the first major part of
the T3SS to be constructed, likely upon a series of scaffold protein rings in both the inner and outer
membrane. Associated with this structure is a cytoplasmic ring (C-ring) that forms a complex with an
essential ATPase and accessory proteins.
After the secretion of needle subunits through the basal body and their assembly into a helical
structure [37], the translocon proteins are likewise secreted to the needle tip. The proteins SctE (for
secretion and cellular translocation protein E), SctB and SctA (Shigella invasion plasmid antigen (Ipa)
B, IpaC and IpaD; Yersinia outer protein (Yop) B, YopD and low calcium respeons protein (Lcr) V;
E. coli secreted protein (Esp) D, EspB and no homolog, respectively) form the translocon [31,38–40].
Whilst SctA controls secretion whilst at the needle tip (in some cases together with SctE [39,41]),
SctE and SctB associate upon activation of secretion, forming a pore in the target cell membrane [42].
Upon host cell contact, the translocon transduces a signal back into the cytoplasm; sometimes this
signal is due to host contact-dependent conformational changes in proteins (e.g., IpaD [42]) from
the tip downwards, whereas in other T3SSs, the process is chemical in nature, such as a change in
pH [43]. A so-called “gatekeeper” protein, localized in the cytoplasm, SctW, serves to prevent effector
protein passage through the export apparatus and is typically displaced by the mechanical or chemical
changes after host cell contact [43]. For example, the gatekeeper MxiC’s release from the Shigella T3SS
structure allows for secretion of bona fide effector proteins [44]. Similarly, during regulation of the
EPEC LEE T3SS, the MxiC-like protein SepL binds specifically to Tir and delays its secretion until the
translocon has correctly formed [45]. In Yersinia, an extra layer of regulation exists in the form of a
YopN-dependent “calcium block” that represses expression and secretion of effector proteins in either
the presence of calcium or the absence of target cell contact [46]. The structure of the YopN–TyeA
complex involved in this process is somewhat reminiscent of MxiC [47] and SepL [45].
2.1.3. Effector Proteins
The substrates secreted into host cells through the T3SS, known as effector proteins, are typically
encoded both in the pathogenicity island (alongside the T3SS structural genes) as well as elsewhere
on the relevant virulence plasmids and chromosomal DNA [27,30,48,49]. Whilst there is significant
homology evident in the structural T3SS proteins from different species, their effectors are much more
species-restricted (Table 1). Effector proteins are divided into “early” and “late” effectors, the former
category including proteins already discussed in Shigella, such as IpaB and IpaC, that regulate secretion and
pore formation. Other early Shigella effectors include proteins such as IpaA [50] that interact specifically
with host proteins to trigger changes in the host cytoskeleton, and IcsB, which acts as a chaperone to
protect the invading microbe from autophagy induced by the autotransporter Intercellular spread protein
A (IcsA) [51]. There is also evidence that the translocon protein IpaC can itself cause host cytoskeletal
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modification [52]. Its EPEC homologue, EspB, similarly has a multifunction role as a secreted immune
suppressor [53,54] as well as translocon component, and is discussed in more detail later in this review.
Exploring the functions of all T3SS effector molecules across the various diarrhoeagenic pathogens
is beyond the scope of this review, though this has been covered in excellent detail elsewhere [28,55–58].
Typically, effectors act as “cytoskeletoxins” that interact with the host cell cytoskeleton in order to cause
macropinocytosis of the pathogen, rearrangements of the actin cortex, or to disable the host immune system.
Key effectors are described for individual species in their respective sections, where appropriate.
Table 1. Type 3 secretion system (T3SS) effector protein nomenclature.
Sct Name a Shigella andEIEC Yersinia
b EPEC and EHEC Proposed Function Reference
− − − EspA Filamentous bridge from needle to host [22,59]
− − − EspF Phagocytosis inhibition, microvilluseffacement, induction of apoptosis [53,60]
− − − EspFU Actin pedestal formation (EHEC only) [61]
EspH Phagocytosis inhibition via indirect RhoGTPase subversion [53]
− − − EspJ Phagocytosis inhibition via ADP ribosylationof host kinases [62]
− − − EspZ Regulation of effector translocation [63]
− IcsB − − Autophagosome escape [64]
− IpaA − − Binds/activates vinculin [65]
SctE IpaB YopB EspD Translocon (pore forming) [42,66,67]
SctB IpaC YopD EspB Translocon (pore forming; secreted effector) [42,68,69]
SctA IpaD LcrV − Translocon (regulation of secretion) [70,71]
− IpaH YopM − Immune subversion via E3 ubiquitin ligaseactivity [72,73]
− IpaJ − − Golgi body fragmentation [74]
− IpgB1/2 − EspM/EspT/Map Host cytoskeleton remodelling via RhoGTPase activity [75,76]
− IpgD − − Host cytoskeleton remodelling via ARF6activation [77]
− − − LifA/Efa1(lymphostatin) Adhesin/toxin [78]
− OspB − − Reduced cytokine production [79]
− OspC1 − − Increased neutrophil migration (bacterialaccess to submucosa) [80]
− OspC3 − − Pyroptosis inhibition via caspase-4interference [81]
− OspD1 − − Regulation of secretion [82]
− OspD2 − EspL c Pyroptosis inhibition via regulation of VirAtranslocation [83,84]
− OspD3(ShET2) − EspL2 d Enterotoxin [85,86]
− OspE1/2 − EspO1/2 Adhesin; actin stabilisation [87,88]
− OspF − − Reduced cytokine production and increasedneutrophil migration [79,80]
− OspG YspK NleH1/2 NF-κB attenuation via ubiquitin binding [89]
− OspI CHYP Cif Inhibits TRAF6 activation via UBC13deamidation [90,91]
− OspZ NleE Increased neutrophil migration (bacterialaccess to submucosa) [92]
− − − Tir Actin pedestal formation [93]
− VirA − EspG Autophagosome escape [64]
− − YopE − Regulation; Rho GTPase activation [94]
− − YopH − Immune subversion via phosphotyrosinephosphatase activity [95]
− − YopP (YopJ) − Immune subversion via NF-κB attenuation [96]
− − YopO(YpkA) −
Prevents phagocytosis via phosphorylation
of actin regulators [97]
− − YopT − Immune subversion via Rho GTPase cleavage [98]
a Unified T3SS nomenclature as proposed by Wagner and Diepold [31]. b If different, Yersinia enterocolitica
nomenclature is given first; Y. pseudotuberculosis/pestis nomenclature follows in parentheses. c OspD2 shows sequence
homology to EspL but is not a cysteine protease. d EspL2 shows sequence homology to OspD3 but is not reported to
have enterotoxin activity.
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2.2. Type 5 Secretion Systems
T5SSs are the simplest and most widespread secretion systems among Gram-negative bacteria [99].
T5SSs are often referred to as autotransporters, due to the original view that these constitute self-contained
secretion systems [100]. However, work during the past two decades has demonstrated that T5SSs
are dependent on several constitutive machineries of the bacterial cell, including the Sec translocon,
periplasmic chaperones and the β-barrel assembly machinery in the outer membrane [101,102]. There are
currently five recognized subclasses in the T5SS scheme. Three of these are relevant for this review:
T5aSSs or classical autotransporters, T5cSSs or trimeric autotransporter adhesins (TAAs), and T5eSSs
or inverse autotransporters (Figure 2). These three share the same basic architecture, with an outer
membrane-embedded β-barrel translocator and an extracellular region or passenger. The passenger
harbours the specific function of the autotransporter, whereas theβ-barrel domain is required for passenger
secretion. In classical autotransporters, the passenger is at the N-terminus of the protein and is in many
cases proteolytically cleaved from the β-barrel [103]. By contrast, inverse autotransporters have the
opposite topology to classical autotransporters, and consequently the passenger is at the C-terminus
of the protein [104]. TAAs have a topology similar to classical autotransporters, but these are obligate
homotrimeric proteins where both the N-terminal passenger and the β-barrel domain are formed by
three identical polypeptide chains [105,106]. Classical autotransporters may have a number of functions,
ranging from adhesion and autoaggregation to enzymatic activity and functioning as toxins. However, all
characterized inverse autotransporters and TAAs have adhesive functions, but may also be involved in
immune evasion or host cell invasion [103]. T5SSs found in enterobacterial pathogens are summarized
in Table 2.
Figure 2. Schematic of type 5 secretion systems. Extracellular passengers are in blue, outer membrane
β-barrels in purple and linkers connecting theβ-barrel to the passenger in red. The passengers of T5aSSs
are typically β-helical structures. T5cSSs or TAAs are formed by three identical chains. The passengers
of TAAs like YadA consist of a coiled coil stalk and an N-terminal β-structured head domain [102],
though more complicated architectures exist. T5eSSs, or inverse autotransporters, such as intimin
and invasin have passengers consisting of tandem immunoglobulin-like domains often capped by a
lectin-like domain. The transmembrane of all three classes consist of a 12-standed β-barrel (with three
chains each contributing four β-strands in the case of TAAs) with the linker(s) contained within the
hydrophilic lumen of the barrel [102]. The periplasmic LysM domain of inverse autotransporters is
shown in orange. The positions of the N- and C-termini are indicated. The figure is adapted from [103].
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Table 2. Characterized autotransporters of pathogenic enterobacteria.
Organisms Autotransporters T5SS Subclass Proposed Function Reference
EHEC, EPEC
Cah 5a Autoaggregation and biofilm formation [107]
EhaA 5a Autoaggregation and biofilm formation [108]
EhaB 5a Binding to extracellular matrix (ECM)molecules, biofilm formation [109]
EhaD a 5a Biofilm formation [108]
EhaG 5c Binding to ECM molecules, biofilm formation [110]
EhaJ 5a Binding to ECM molecules, biofilm formation [111]
EspC b 5a Regulation of T3SS secretion, cytotoxin [112]
EspP a 5a
Regulation of T3SS, cleavage of coagulation
and complement factors, formation of
rope-like adhesive aggregates
[112]
FdeC 5e Binding to host cells and ECM molecules,autoaggregation and biofilm formation [113]
IatB 5e Biofilm formation [114]
IatD 5e Biofilm formation [114]
Intimin 5e Binding to Tir; actin pedestal formation [115]
YeeJ 5e Biofilm formation [116]
EIEC, Shigella sp.
IcsA 5a Adhesion to host cells; actin-basedintracellular motility [117]
Pic 5a Mucin degradation, serum resistance [112]
Sat c 5a Cytotoxin [112]
SepA c 5a Disruption of apical pole of polarizedepithelial cells, facilitation of invasion [112]
SigA c 5a Cytotoxin [112]
Yersinia enterocolitica, Y.
pseudotuberculosis
Invasin (InvA) 5e Binding to β1 integrins; invasion of M cells [118]
Ifp (InvB) d 5e Binding to and invasion of epithelial cells [119]
InvC 5e Binding to epithelial cells [120]
InvD d 5e
Binding to Fab fragment of immunoglobulins,
binding to B cells [121]
YadA 5c
Binding to ECM molecules and serum
components; host cell adhesion and immune
evasion
[122]
YapC d 5a
Autoaggregation and biofilm formation,
binding to host cells [123]
YapE 5a Autoaggregation, binding to host cells [124]
YapV d 5a Binding to N-WASP and ECM molecules [125]
a Only in EHEC; b only in EPEC; c only in Shigella spp.; d only in Y. pseudotuberculosis.
3. Staying out: The Attaching and Effacing Pathogens
The attaching and effacing (A/E) pathogens, including EPEC and EHEC, are primarily extracellular
bacteria characterized by binding to the luminal surface of enterocytes, which leads to the resorption
of microvilli (effacing of enterocytes) and the formation of a protrusion from the cell, called a pedestal,
that acts as a platform for these bacteria (Figure 3). Microvillus effacement and pedestal formation
are driven by rearrangement of the actin cortex. These phenomena are dependent on a horizontally
acquired pathogenicity island, the LEE, which encodes a T3SS, effector proteins, transcriptional
regulators, and an adhesin, intimin [126]. Pedestal formation and intimate contact are necessary for
virulence of A/E pathogens, and the LEE is an essential virulence factor. While the function of pedestal
formation remains somewhat mysterious, this presumably prevents dissociation of the bacteria from
the epithelium and promotes the changes needed for diarrhoeagenesis [127]. In addition, recent
evidence points to pedestal formation protecting the bacteria from phagocytosis [128].
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Figure 3. Schematic of the major steps in pedestal formation by attaching and effacing pathogens.
The bacteria initially bind to the enterocytes via adhesins, allowing the Esc T3SS to inject effector
proteins. These include Tir, which is inserted into the plasma membrane of the target cell where it
binds to the inverse autotransporter intimin, present on the bacterial surface. The binding of intimin
to Tir leads to intimate attachment and Tir clustering, resulting in recruitment of N-WASP, actin
rearrangements and pedestal formation. Thus, the LEE-encoded T3SS and T5SS (intimin) act together
to form the A/E lesion.Schematic of the major steps in pedestal formation by attaching and effacing
pathogens. The bacteria initially bind to the enterocytes via adhesins, allowing the Esc T3SS to inject
effector proteins. These include Tir, which is inserted into the plasma membrane of the target cell
where it binds to the inverse autotransporter intimin, present on the bacterial surface. The binding of
intimin to Tir leads to intimate attachment and Tir clustering, resulting in recruitment of N-WASP, actin
rearrangements and pedestal formation. Thus, the LEE-encoded T3SS and T5SS (intimin) act together
to form the A/E lesion.
The LEE can vary in size and composition. The ~35 kb LEE from the EPEC strain E2349/69 can be
considered to represent a “core” LEE, whereas other A/E strains contain flanking regions that can extend
the pathogenicity island to over 100 kb in length [126]. The flanking regions often contain insertion
elements, prophage sequences, or additional effector proteins. In some strains, the 3′ flanking regions
contain an element encoding the non-LEE effectors Ent, NleA, NleB and a large toxin, lymphostatin,
which has been implicated in haemolytic uremic syndrome [78,126,129].
The LEE is subject to complex genetic regulation. The core LEE itself encodes three regulators,
Ler, GrlA and GrlR [130]. Ler is the master regulator of the other LEE genes. At temperatures
below 37 ◦C, the histone-like nucleoid structuring protein H-NS represses ler and other LEE genes;
at 37 ◦C, ler is expressed and leads to the expression of other LEE-encoded factors. However,
many other environmental cues regulate ler expression, including quorum sensing, oxygen levels,
biotin concentration, intracellular iron, host hormones, metabolites such as butyrate, fucose,
and phosphorylated fructose species, and attachment to host cells [131]. Furthermore, the LEE
is internally regulated by the interplay of GrlA, a positive regulator, and GrlR, a negative regulator,
which fine tunes the expression of LEE components [132,133]. Thus, the regulatory network controlling
LEE expression must integrate a variety of signals to finely tune the expression levels of the LEE-encoded
factors [130,131].
3.1. The Esc-Esp T3SS
The Esc T3SS (also called ETT1) of EPEC and EHEC is encoded by the LEE. This is a major
virulence factor of both organisms and is responsible for translocating toxic effectors, generally called
Escherichia coli secreted proteins (Esps). The main targets of the Esc T3SS are the intestinal epithelial
cells, but Esc can also target immune cells. The effectors translocated by the Esc T3SS of EPEC and
EHEC lead to rearrangement of the cytoskeleton, subvert innate immune responses, compromise the
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epithelial barrier function and modulate cell survival [53]. Seven effectors are encoded by the LEE
(EspB, EspF, EspG, EspH, EspZ, Map and Tir), but in addition, several non-LEE effector genes located
elsewhere in the genome have been identified. Typical EPEC strains encode ~20 effectors, whereas
some EHEC strain encode close to 40 [26]. Therefore, only the “core” Esp effectors and a couple of
noteworthy non-LEE effectors will be considered here (Table 1).
The LEE-encoded Esc substrates include EspA, EspB and EspD (Table 1). These are not effector
proteins as such, but rather play a structural role. EspA polymerizes to form the extracellular filament
connecting the needle to the host cells, whereas EspB and EspD form the translocon pore in the
host cell membrane (Figure 1) [26]. In addition, EspB has a true effector function in host cells in
preventing phagocytosis. EspB interacts with myosin, preventing the formation of pseudopods and
phagosome closure [53]. Other effectors that influence phagocytosis include EspF, EspH and EspJ
(Table 1). EspF inhibits phagocytosis by interfering with phosphoinositide 3-kinase signalling and
subsequent F-actin rearrangements [53]. EspF is a multifunctional protein, and in addition to preventing
phagocytosis, also targets tight junctions in epithelial cells, contributes to microvillus effacement and
can induce apoptosis [60]. EspJ prevents phagocytosis of opsonized cells by macrophages through
ADP-ribosylating several cytoplasmic host kinases [62]. EspH prevents activation of the small GTPases
of the Rho family by binding to nucleotide exchange factors [53]. Map, EspM and EspT are all guanine
nucleotide exchange factors that modulate cytoskeletal function through small GTPases (Table 1); Map
activates Cdc42 and promotes the formation of filopodia, EspM targets RhoA to increase stress fiber
production, and EspT activates both Cdc42 and Rac1 leading to membrane ruffling and the formation
of filopodia [134]. The final LEE-encoded effector, EspZ, regulates the translocation of other effectors
and thereby modulates their intracellular activity [63].
The most abundantly secreted effector is the translocated intimin receptor, Tir. This is also the
central effector protein for virulence and binding of Tir by intimin is sufficient to promote actin
cytoskeleton rearrangements leading to pedestal formation in EPEC [135]. However, it should be
noted that in vivo, other effectors including non-LEE effectors are needed to form full A/E lesions by
EPEC [48]. In EHEC, a second non-LEE effector, EspFU (formerly TccP), interacts with Tir to mediate
pedestal formation [61]. Pedestal formation is discussed in more detail in Section 3.3.
Interestingly, the Esc T3SS does not only translocate classical effector proteins. In EPEC, the T5a
autotransporter EspC is also transported into host cells in a T3SS-dependent manner [136]. EspC
is a serine protease that is first secreted into the extracellular medium by the T5SS, after which the
passenger is autoproteolytically cleaved from the β-barrel domain [112]. Outside the bacterium, EspC
regulates T3SS function externally by cleaving the translocon protein EspD and the filament protein
EspA [137]. EspC only targets the EspA–EspD complex that is secreted upon host cell contact; however,
polymerized EspA in the injectisome filament is not degraded by EspC. The result of this degradation
is regulation of the number of T3SS pores formed on the host cell and a subsequent reduction in
cytotoxicity of the pores. EspC thus acts as a negative regulator of the T3SS and prevents premature cell
death of epithelial cells due to T3SS cytotoxicity [137]. The related protein EspP of EHEC has a similar
function to EspC and can cleave EspA, EspB and EspD to negatively regulate the Esc T3SS [138].
EspC apparently has some other extracellular functions. Like the EHEC protein EspP, the EspC
passenger can form multiprotein filamentous structures called “ropes”, which have cytopathic and
adhesive properties and can act a substrate for biofilm formation by the bacteria [139]. Further, EspC
is able to degrade hemoglobin and bind to hemin, which suggests that EspC may play a role in iron
acquisition by EPEC [140].
More surprising are the intracellular effects of EspC, where it causes changes in the actin
cytoskeleton, cell rounding and detachment [112]. It does this by targeting fodrin, a protein that
anchors the actin cortex to the plasma membrane, and two focal adhesion proteins, paxillin and focal
adhesion kinase (FAK) [141]. In addition, procaspase-3 is activated, leading to apoptosis [142]. To enter
host cells, the EspC passenger binds to EspA on the outside of the injectisome and then interacts with
EspB and EspD to enter the host cell [36]. The relationship between the T5SS EspC and the Esc T3SS
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demonstrates again how the two secretion systems often act together to promote virulence. To our
knowledge, there are no published studies or hypotheses for how the dual (extra- and intracellular)
functions of EspC might have evolved, but its several functions are in keeping with the observations
that many autotransporters are multifunctional proteins.
3.2. Intimin
Intimin is an adhesin and an essential virulence factor of A/E pathogens. It is also the prototype of
the T5eSS [104,143]. Intimin consists of a 12-stranded β-barrel domain followed by a passenger formed
by four immunoglobulin(Ig)-like domains capped by a lectin-like domain at the C-terminus [144,145].
The receptor binding region is formed by the terminal Ig-like domain and the lectin-like domain [144].
In addition, intimin has a short N-terminal periplasmic region including a peptidoglycan-binding
LysM minidomain [146]. The two C-terminal domains form a superdomain that interacts with its
receptor, Tir. Both proteins function as dimers: Tir recruits two intimins but, as shown by the crystal
structure of the complex, these are most likely from two separate intimin dimers [144,147]. This would
lead to an intimin–Tir network at the attachment interface, which would cluster intracellular signalling
molecules, leading to downstream effects promoting pedestal formation (see 3.3. below) [146,147].
There are 18 different subtypes of eae, the gene for intimin, with at least 27 alleles [115]. The most
clinically important types are intimin-α, associated with typical EPEC strains, intimin-β, found in some
EPEC and EHEC strains and Citrobacter rodentium, and intimin-γ, associated with EHEC O157:H7.
The different intimin isoforms have been implicated in the tissue tropism of the producer bacteria.
For example, EHEC usually colonizes the epithelium covering ileal Peyer’s patches, the lymphoid
follicles of the intestinal tract. In contrast, EPEC colonizes the epithelium of the small intestine.
Introducing the eae gene encoding intimin-γ into a ∆eae EPEC strain switched the tropism to Peyer’s
patches [148]. The intimin subtype may also play a role in host specificity: intimin-γ cannot complement
the lack of intimin- β in a murine infection model with C. rodentium, and conversely intimin-β cannot
restore normal colonisation patterns to a ∆eae EHEC strain in a porcine organ culture model [149].
However, more recent work, where intimin subtypes were expressed from the chromosomal locus
rather than a plasmid, did not show similar changes in tissue tropism [150]. Thus, the role of intimin
subtypes in the tissue tropism of different pathogens still requires clarification.
3.3. Pedestal Formation
After translocation into the host cell, Tir integrates into the host plasma membrane to act as the
receptor for intimin [93]. Tir is a bitopic transmembrane protein with both the C- and N-termini
located in the host cell cytoplasm [151]. Tir also forms homodimers, and the dimerisation is mediated
by the extracellular intimin-binding domain [144]. Dimerisation of Tir is important for downstream
effects, as this leads to formation of an intimin–Tir network needed for inducing actin rearrangements
and pedestal formation [147,150]. In EPEC infections, a central step leading to actin cytoskeletal
remodelling is Tir phosphorylation at Y474 [152]. This is mediated by various kinases and is dependent
on intimin mediated-Tir clustering [153–156]. Phosphorylated Y474 binds the adaptor protein Nck [157].
This leads to recruitment of neural Wiskott–Aldrich syndrome protein (N-WASP) and ultimately actin
polymerisation via the Arp2/3 complex. A recent study demonstrated a role for the formin mDia1 in
pedestal assembly [158]
By contrast, EHEC uses a different mechanism for pedestal formation. EHEC Tir is not dependent
on tyrosine phosphorylation; in fact, it lacks an equivalent to Y474 [159]. It is also independent of the Nck
pathway. Rather, actin assembly for pedestal formation requires an EHEC-specific, non-LEE-encoded
effector, EspFU, which binds to Tir in the host cytoplasm [61]. EspFU recruits two host proteins, IRSp53
and IRTSK, to form a complex that activates N-WASP and Arp2/3 [160,161]. As for EPEC, this leads
to actin polymerisation at the site of intimate contact and pedestal formation. The difference in the
way actin polymerisation takes place in EHEC and EPEC infections explains why EHEC Tir cannot
complement the Tir from EPEC. The EspFU pathway has some differences in outcomes compared with
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the Tir-Nck pathway used by EPEC: firstly, the EspFU pathway promotes a greater degree of adhesion
and more colonisation of the epithelium than the Tir-Nck pathway [162]. Secondly, the EspFU pathway
promotes more efficient cell-to-cell spreading. A/E pathogens can use a type of actin-based motility
(ABM) called surfing motility, where the bacteria together with the entire actin pedestal glide along the
surface of the cell. This allows spreading of the bacteria over the apical surface of the epithelium and
the formation of “microcolonies”; the EspFU pathway is more efficient in this and leads to faster and
larger microcolony formation [128].
The intimin–Tir interaction is needed for intimate attachment and pedestal formation. However,
if binding of intimin to Tir is needed for efficient effector translocation, this creates a chicken-and-egg
problem: how can intimin mediate translocation of Tir if Tir is not already present on the host cell
surface? A possible explanation is that intimin binds to endogenous receptors on enterocytes, which
would also explain the different tissue tropism seen between different intimin subtypes [148,149].
Intimin has been suggested to bind to β 1 integrins and cell surface-localized nucleolin [163–165];
these interactions could aid in docking the Esc T3SS to the host cell surface to inject effectors. However,
the interactions with host proteins remain poorly characterized and the binding toβ 1 integrins has been
contested [166]. In addition, intimin interactions have been widely investigated using “prime-challenge”
experiments, where cell cultures are first infected with a ∆eae EPEC strain, leading to Tir translocation
into the cells [135,150,167]. The bacteria are then removed before adding intimin-expressing laboratory
E. coli strains that bind to the Tir-containing host cells. This experimental set-up strongly suggests
adhesins other than Tir are needed for the initial binding and initiation of effector secretion. In EPEC,
candidates for initial adhesion include bundle-forming pili [168] and E. coli common pili [169], as well
as several autotransporters (Table 2). It also appears that the T3SS itself can mediate a low level of
adhesion [168,170]. In EHEC, long polar fimbriae and other pili and several type 5a and 5c adhesins
(Table 2) might contribute to initial adhesion and T3SS docking [115].
4. Going in: EIEC and Shigella
Both Shigella and EIEC are characterized by their ability to invade the human intestinal epithelium
followed by intracellular replication and dissemination. As depicted in Figure 4, the highly adapted
organism firstly invades through the human microfold (M) cells located in the epithelium covering
Peyer’s patches, the lymphoid follicles of the intestine [171]. The subsequent release to the basolateral
side of the epithelium results in uptake of the bacteria by the host macrophage. Here, the avoidance
of phagocytosis is achieved via rapidly induced apoptosis. This allows the bacteria to invade the
epithelium from the basolateral side, where they can spread from cell to cell resulting in inflammatory
destruction. Shigella are a group of bacteria incredibly adapted to life inside of the human host having
lost a substantial number of genes vital for survival in the environment yet unnecessary inside the
host. The highly adapted modifications in metabolic and pathogenic profiles of Shigella are not yet
as advanced in EIEC. EIEC, being metabolically closer to E. coli, has not experienced the loss of
anti-virulence genes and adaptive mutational events limited to Shigella [25]. The metabolic differences
between the two species allow differentiation of the two pathogens, even though 16S RNA-based
differentiation is not possible. For example, the utilisation of lactose on MacConkey medium is a classic
way to separate the two species [172].
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Figure 4. Schematic of the key steps in Shigella invasion and cell-to-cell spread through the intestinal
epithelium. The bacteria firstly inject effectors via the T3SS into the host M cell to promote cytoskeletal
remodelling. The actin-rich membrane ruffles engulf the bacteria followed by transcytosis and
subsequent release from the M cell at the basolateral side. Here the bacteria are taken up by host
macrophages where they induce rapid apoptosis through T3SS effectors, thus releasing the bacteria
onto the basolateral surface of the epithelium. The bacteria then invade the epithelial cells via the T3SS.
Following invasion, the bacteria recruit host actin to form “actin tails” via the autotransporter IcsA for
intracellular dissemination for rapid lateral spread through the epithelium. The combination of the
T3SS and T5SS allow the bacteria to invade and spread inter- and intracellularly.
4.1. The Invasion Process
It is widely acknowledged that the acquisition of the large virulence plasmid, pINV, in both
Shigella and EIEC was fundamental to establishing their virulence, enabling the bacteria to invade and
spread through the human intestinal epithelium resulting in the inflammatory destruction referred to
as bacillary dysentery [173]. Essential for this process, pINV produces a T3SS encoded by the conserved
mxi-spa locus, allowing the pathogens to establish a safe and nutrient-rich environmental niche inside
the host [174]. Not only does the T3SS control invasion into the host intestinal epithelium but further
controls the intra- and intercellular spread, macrophage cell death and host inflammatory responses.
The pINV-encoded virulence genes required for infection are under tight control via the primary
transcriptional regulator VirF, with their expression governed by various environmental stimuli within
the host.
The Shigella invasion process is primarily regulated by the temperature of the human body.
The transcriptional regulator VirF is optimally expressed at 37 ◦C, resulting in the activation of virB
and icsA expression [175]. The Shigella T3SS is also precisely regulated in response to varying levels of
oxygen throughout the gastrointestinal tract. In anaerobic conditions present in the gastrointestinal
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tract lumen, Ipa effector protein secretion is significantly reduced and the T3SS needle is extended,
although is not yet effective for secretion. This regulation is mediated by the FNR transcriptional
regulator, which is active in low oxygen conditions and is responsible for the repression of spa32
(sctP; regulating needle length) and spa33 (sctO; the C-ring) [176,177]. The area adjacent to the
mucosa is, however, sufficiently oxygenated to prevent FNR activity and trigger T3SS activation for
effective invasion. This complex regulation allows the accumulation of virulence proteins in anaerobic
conditions, ready for use once the bacteria encounter the epithelium [176,178].
Following T3SS assembly at 37 ◦C, contact with M cells [171] is required to facilitate the translocation
of effector proteins into the host cell cytosol through the T3SS needle [44]. The host filament vimentin,
whilst dispensable for pore formation itself, triggers docking of the T3SS to the pore [179], a process
that is enabled by a conformational change in IpaC [180]. The Shigella proteins IpaB, IpaC and IpaD
form the translocon [38–40], and IpaD and MxiC regulate the secretion of effectors [41,44]. The secreted
effectors (Table 1) trigger cytoskeletal remodelling, consequently resulting in the formation of transient
actin-rich membrane ruffles which engulf the infecting bacterium within a vacuole [42]. Following
transcytosis, Shigella/EIEC are released from the M cell where they encounter resident macrophages [55].
These pathogens are able to survive the degrading effects of macrophages through the rapid induction
of apoptosis prior to their release into the basolateral surface of the epithelium, from where they invade
the neighbouring epithelial cells via a macropinocytic process [174,181]. At the basolateral surface,
glucosylation of lipopolysaccharides allows the T3SS to contact the epithelium in addition to increased
immune evasion. It is thought that IpaB, localized at the needle tip, binds to C44 lipid microdomains
to uphold contact to the epithelial cell [28,182]. Faherty et al. further noted that ospE1/ospE2 genes
were induced in the presence of bile. The OspE1/OspE2 effectors secreted by the T3SS were shown
to remain localized on the bacterial outer membrane where they may act as adhesins in response to
bile salts [87]. At this stage of infection, proinflammatory cytokines interleukin (IL)-1β and IL-18 are
released, characteristic of the large inflammatory response associated with shigellosis [55,183].
4.2. Actin-Based Motility
Shigella and EIEC are typically non-flagellated. Once in the epithelial cell cytoplasm, the bacterium
begins recruiting host actin to form “actin tails” used to propel the bacteria, allowing intracellular
movement and dissemination from cell to cell. This results in rapid lateral spread through the epithelial
layer without the need for re-entry through the basolateral pocket [184,185]. This method of infection
allows the bacteria to reside and replicate within the host cells, minimising exposure to the immune
response. This ABM is highly dependent upon the surface-exposed type 5a autotransporter IcsA,
also known as VirG. IcsA is regulated by VirF and is responsible for the recruitment and polymerisation
of the host actin at one pole of the bacterial cell [186,187]. The N-terminus of the passenger interacts
with host proteins such as vinculin and N-WASP, leading to the subsequent actin polymerisation at
one pole of the bacterium [188,189].
In addition to ABM, the multifunctional role of IcsA as an adhesin has also been investigated.
Following the knockout of T3SS translocon proteins IpaD and IpaB in S. flexneri, polar adhesion to
host cells was observed in an IcsA-dependent manner [117]. The expression of IcsA in E. coli further
supported this hypothesis as the protein was found to promote adherence to host cells. However,
detectable adherence was not identified unless exposed to environmental stimuli, such as the bile salt
deoxycholate [190], or via T3SS activation [117]. Qin et al. went on to identify the specific binding region
within the passenger domain responsible for adhesion [191]. Interestingly, an icsA adhesion-defective
mutant obtained via insertions into the passenger resulted in an attenuated infection phenotype using
the Sereny test [117]. In addition to its roles in ABM and host cell adhesion, IcsA also plays a key role
in S. flexneri biofilm formation in the presence of deoxycholate by promoting cell-to-cell contact and
aggregative bacterial growth [192]. This multifunctional protein therefore plays a key role in Shigella
pathogenesis specifically promoting ABM, host cell adhesion and biofilm formation under varying
environmental niches. IcsA is therefore both necessary and sufficient for host cell contact enhancing
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pathogenesis. Although to our knowledge this has not been studied, it is possible that IcsA is also
needed for docking the T3SS to the host cell surface, similarly to YadA in the enteropathogenic Yersiniae
(see Section 5.2).
4.3. EIEC vs. Shigella
Despite the remarkable similarities between EIEC and Shigella invasion, it has been well
documented that EIEC infection requires a higher infectious dose, resulting in a much milder
disease compared to Shigella [25]. The main differences centre around macrophage escape and
intracellular dissemination [193,194]. Induced apoptosis resulting in macrophage escape is a key step
in intestinal colonisation for both Shigella and EIEC. However, comparative studies have demonstrated
EIEC’s reduced efficiency of murine J774 macrophage escape and cell-to-cell spread, as well as the
lowered effectiveness of cell killing during the first 4 h post infection when compared to Shigella [194].
During earlier stages of Shigella infection, Moreno and co-workers observed that the keratoconjunctivitis
model gave more severe results, with Shigella inducing a greater proinflammatory response compared
EIEC infection [193]. Whilst EIEC and Shigella share the same virulence factors and mode of
invasion [195], despite the clear differences in disease development, investigation turned to the
relationship between EIEC virulence gene expression profiles and the reduced ability to cause disease.
During invasion, ipaABCD expression is reduced in EIEC compared to S. flexneri. More specifically,
ipaC showed the greatest diminished expression during EIEC intracellular infection despite its key
role in phagosome escape [196,197] and epithelial invasion [193,198] thus supporting the diminished
macrophage death and cell-to-cell spread previously mentioned. Interestingly, this reduced expression
is not true for all EIEC invasion-associated virulence genes. Moreno et al. [193] documented higher
levels of virF expression in EIEC compared to Shigella intracellularly during dissemination. This might
be attributed to the translation of virF mRNA into two separate proteins of 30 kDa and 21 kDa [199].
The shorter protein negatively autoregulates virF expression, modulating intracellular VirF levels.
The large variations in disease severity despite the similar mode of infection highlights the importance
of the efficiency of virulence gene transcription and regulation. These variabilities in gene regulation
and response to environmental stimuli may underpin the resulting differences in disease outcomes.
Overall, the acquisition of the T3SS was essential for both Shigella and EIEC to invade, disseminate
and survive within the host during infection. Their unique mode of infection demonstrates the
highly conserved regulation of essential virulence genes involved in infection and its ability to cause
disease. The complex regulation involved in T3SS expression is precisely adapted to the human host,
resulting in extremely efficient invasion and spread leading to severe disease. Both the T3SS and
the autotransporter IcsA result in changes to the actin cytoskeleton, with IcsA also playing a key
role as an adhesin enhancing pathogenesis. Shigella is highly adapted for optimal invasion within
the human host, especially when compared to EIEC, portraying the importance of virulence gene
expression efficiencies.
5. Maybe Going in? The Enteropathogenic Yersiniae
The enteropathogenic Yersiniae, Y. enterocolitica and Y. pseudotuberculosis, have a very similar
lifestyle and mode of infection. Both organisms are transmitted by the faecal–oral route. Once they
reach the terminal ilium, the bacteria invade M cells [200]. The bacteria are transcytosed through the
M cells and released into the Peyer’s patch, where they establish a primarily extracellular infection.
From the Peyer’s patches, the enteropathogenic Yersiniae disseminate to the mesenteric lymph nodes to
cause a usually self-limiting infection. In rare cases, the bacteria can spread to other organs, particularly
the liver and the spleen, to cause a systemic infection. There is evidence for direct dissemination
from the intestinal lumen to the liver, possibly via the hepatic portal vein [201,202]. This can happen
particularly in cases of iron overload in the bloodstream, e.g., due to genetic factors [203]. In addition,
a pool of replicating bacteria remains in the intestinal lumen, which is presumably responsible for the
diarrhoeal component of the infection [201].
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Pathogenesis of enteric yersiniosis is dependent on three major virulence factors. These are
the autotransporter adhesins invasin (InvA) and YadA and the plasmid-encoded T3SS, Ysc, and its
effectors, the Yersinia outer proteins or Yops [203]. These three virulence factors, InvA, YadA and
Ysc-Yops, all elicit cytoskeletal changes in host cells and act in concert to establish an extracellular
infection in lymphatic tissues. The paradigm for the classical Yersinia infection route has been that
InvA is expressed first and mediates invasion of the intestinal epithelium. Once within the submucosa,
YadA and Ysc are expressed and together promote an extracellular infection in the lymphatic tissues by
targeting leukocytes and preventing phagocytosis of the bacteria (Figure 5A). The latter two factors are
essential for virulence in Y. enterocolitica, whereas lack of InvA delays the onset of infection [204,205].
In contrast, only Ysc is essential for Y. pseudotuberculosis pathogenicity [206]. Interestingly, in the plague
bacillus Y. pestis, both invA and yadA are inactivated though Ysc is still required for infection [207].
The lack of the adhesins probably reflects the altered infection route of Y. pestis: this organism is
transmitted subcutaneously by flea bites, or by aerosols in the case of pneumonic plague, not through
the intestinal tract.
Figure 5. Schematic of enteropathogenic Yersinia pathogenesis. (A) In the distal ileum, Yersiniae bind to
β1 integrin-expressing M cells via the inverse autotransproter invasin. This leads to internalisation
of the bacteria and transcytosis through the M cell into the underlying Peyer’s patch, where the
bacteria come into contact with immune cells such as neutrophils and macrophages. At this stage,
the extracellular bacteria bind to immune cells via the TAA YadA. YadA binds to extracellular matrix
(ECM) molecules such as collagen and fibronectin, which in turn are bound to host cell surface receptors
such as integrins. The binding of YadA to the target cell through a bridging ECM molecule allows
injection of Yops by the Ysc T3SS, which prevents phagocytosis and leads to apoptosis of the immune
cells. In this way, the plasmid-encoded T3SS and T5SS (YadA) act together to evade phagocytosis
and establish an extracellular infection. (B) Mechanism of invasin-mediated internalisation into host
cells by the zipper mechanism. Invasin (orange) binds to β1 integrins on the host cell surface (black
structures). This induces outside-in integrin signalling and changes to the actin cytoskeleton, which
leads to engulfment of the bacteria by a zipper-like mechanism. YadA can also in some cases promote
bacterial uptake by a similar mechanism via a bridging ECM molecule.
Although the Yersiniae have been considered mainly extracellular pathogens, there is mounting
evidence that they can invade host cells other than M cells, and that they can survive and even replicate
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within neutrophils and macrophages [208–212]. Recently, uptake of Y. enterocolitica by dendritic
cells in intestinal tissues was demonstrated [202]. The same study showed that Y. enterocolitica can
disseminate to the spleen independently of Peyer’s patches and mesenteric lymph nodes, and that
this was dependent on mononuclear phagocytes. Y. pseudotuberculosis and Y. pestis encode a type 5a
autotransporter, YapV, which is similar to IcsA and can interact with N-WASP [213]. This suggests that
these bacteria are capable of ABM, again supporting the view of an occasional intracellular lifestyle.
Thus, the paradigm of an obligate extracellular lifestyle once Yersiniae have crossed the intestinal
epithelium should be revised to consider the facultative intracellular nature of these pathogens.
5.1. Invasin
InvA is expressed at environmental temperatures (26 ◦C and below) as well as at higher
temperatures under acidic conditions [214]. The bacteria are therefore thought to be primed with InvA
on the surface when ingested and after transit through the gastrointestinal tract. Recently, InvA was
also showed to be upregulated during persistent infections [215].
InvA is a chromosomally encoded inverse autotransporter similar in structure to intimin [145,216].
However, unlike intimin, InvA binds directly to cellular receptors, the β1 integrins [217]. These are not
normally present on the apical surface of enterocytes; however, M cells do express β 1 integrins on their
apical surface [218,219]. The enteropathogenic Yersiniae bind to these receptors via InvA, which leads to
internalisation of the bacteria by a zipper-like mechanism (Figure 5B). This is a consequence of integrin
clustering, which leads to intracellular signalling events and the formation of focal adhesions and actin
rearrangements [118]. The Y. pseudotuberculosis InvA protein is the more potent mediator of invasion
due to the presence of a self-interaction domain (D2) in the passenger lacking in the Y. enterocolitica
orthologue [220,221]. Integrin clustering leads to phosphorylation of kinases such as FAK and Src,
phosphorylation of the adapter protein Cas and recruitment of Crk, as well as activation of the GTPase
Rac1 [222–224]. This leads to the cytoskeletal arrangements mediated by WASP family members and
the Arp2/3 complex resulting in the engulfment of the bacteria by the zipper mechanism [223,225].
5.2. YadA
In contrast to invA, the expression of yadA is upregulated at 37 ◦C, the mammalian body
temperature [226]. YadA is the prototypical TAA, consisting of a globular head at the N-terminus,
a coiled coil stalk and a C-terminal β-barrel domain. It is encoded on the Yersinia virulence plasmid
pYV [205]. YadA is a multifunctional protein that promotes adhesion to cells and extracellular matrix
(ECM) components, host cell invasion, serum resistance by binding to complement-regulatory factors,
as well as autoaggregation and biofilm formation [122,143]. YadA thus likely contributes to microcolony
formation within the infected tissues by protecting the bacteria from serum and mediating biofilm-like
structures that are resistant to phagocytosis [227,228]. In addition, YadA acts as a scaffold for docking
the Ysc T3SS apparatus onto host cells [229,230]. The length of the YadA stalk and the Ysc injectisome
needle are correlated; genetically increasing the length of YadA or shortening the injectisome led to
inefficient Yop delivery [231]. Both YadA and InvA can provide the docking function for Ysc, but YadA
usually has a much more prominent role for Yop delivery in vivo, though the relative contributions of
the adhesins to Yop delivery are strain-dependent [229,230,232]. The model for the interaction is that
YadA binds to host cells, particularly phagocytes, via a bridging ECM molecule, which then allows
the Ysc system to dock on the host cell surface and inject the Yops (Figure 5A) [229,233]. The host cell
receptors involved in YadA-mediated Ysc docking are suggested to be β1 and αV integrins [229,232].
Indirect binding of YadA to these receptors via an ECM molecule activates similar downstream
signalling events as the direct binding of InvA [234]. In Y. pestis, which lacks both InvA and YadA,
other proteins, such as the small β-barrel protein Ail, can aid in docking the T3SS [235,236]. Similarly,
even in the absence of InvA and YadA, Y. enterocolitica and particularly Y. pseudotuberculosis are able
to inject Yops into leukocytes, though at much reduced rates [230,232]. Ail and other adhesins may
account for this low-level of Yop injection [226,237].
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5.3. The Ysc-Yop T3SS
Like YadA, ysc is encoded by the pYV plasmid and upregulated at 37 ◦C [238]. The main
functions of Ysc-Yops are to prevent phagocytosis of the bacteria and dampen immune responses.
Though in vitro Yersiniae can inject Yops into epithelial cells and fibroblasts [229], the main targets for
Yop injection in vivo appear to be leukocytes, particularly myeloid immune cells such as neutrophils
and macrophages [230,239]. However, in the spleen, also B cells, and to a lesser degree T cells, can be
targeted [230,239].
The effect of Yop injection is manifold. There are ten Yops (Table 1): three (LcrV, YopB and
YopD) are involved in forming the tip of the injectisome and the translocon pore in the host cell
membrane [240]. Another Yop, YopK (YopQ in Y. enterocolitica) is secreted in low amounts and appears
to be involved in regulation of the secretion of other effector Yops [29]. The remaining Yops can be
considered the true effectors with cytotoxic activities (Table 1). Four Yops (YopE, YopH, YopT and
YopO, also called YpkA in Y. pseudotuberculosis and Y. pestis) are cytoskeletoxins that disrupt the actin
cytoskeleton preventing the formation of phagocytic cups. Two of them, YopE and YopT, target Rho
family GTPases [57]. YopE is a GTPase-activating factor that stimulates Rac1, RhoA, RhoG and also
Cdc42 to hydrolyze their GTP cofactor, thus inactivating these proteins and preventing downstream
actin polymerisation [94]. YopT prevents Rho family signalling by a different mechanism: YopT is
a cysteine protease that cleaves the C-termini of Rho family members, thus separating them from
their isoprenyl membrane anchor [98]. Following cleavage by YopT, the Rho proteins diffuse away
from the membrane and their interaction partners, preventing signal propagation. The other two
cytoskeletoxic Yops target phosphorylation of cytoskeletal signalling molecules. YopH is a potent and
promiscuous phosphotyrosine phosphatase that targets several signalling molecules, especially those
involved in the formation of focal adhesion, such as FAK and Cas, which are important for integrin
signalling [95]. By contrast, YopO is a serine/threonine kinase that targets regulators of actin dynamics,
thus preventing actin polymerisation [241].
The two other effectors have anti-inflammatory and pro-apoptotic effects; these are YopM and
YopJ (YopP in Y. enterocolitica) [57]. YopJ is an acetyltransferase that modifies several kinases involved
in signal transduction pathways activating the pro-inflammatory transcription factor NF-B and MAP
kinases [207]. YopM is a leucine-rich repeat protein and the only Yop that appears to lack enzymatic
activity. The molecular mechanism of how YopM exerts its anti-inflammatory function has remained
elusive for a long time. In host cells, YopM can localize to both the cytosol and the nucleus. Interaction
partners include the kinases RSK and PRK; however, the effect of these interactions is unclear. YopM also
inhibits caspase-1, which might prevent pyroptosis of macrophages [72]. Recent evidence shows that
YopM prevents the activation of Pyrin inflammasomes, which are induced by YopJ [242]. Although its
mechanism still remains to be fully elucidated, YopM is a potent anti-inflammatory molecule that plays
an important role in establishing infection.
In the Yersiniae, the T5SS (YadA or InvA) works together with the T3SS to inject Yops into
phagocytes, allowing the bacteria to evade innate immune responses and persist extracellularly in
lymphatic tissues. The association between YadA and the T3SS is yet another example of how the two
secretion systems act together to promote pathogenesis by avoiding phagocytosis through disruption
of the host immune cell cytoskeleton.
6. Conclusions
The enterobacteria are a remarkably versatile group of pathogens. They display very different
lifestyles, even between closely related bacteria. This is exemplified by the many pathovars of E. coli,
including Shigella spp., which cause not only a range of gastrointestinal symptoms but also urinary
tract infections, sepsis and meningitis [243]. The recently diverged Y. pseudotuberculosis and Y. pestis
have completely different lifestyles and disease mechanisms [244].
The enterobacteria are also different regarding cell invasion. We provide examples of both intra-
and extracellular pathogens, as well as facultatively intracellular bacteria. However, it should be noted
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that the distinction between extracellular, intracellular and facultative intracellular lifestyles are not
clear-cut. EPEC and EHEC, though generally considered extracellular pathogens, can in some cases
invade host cells [245–247]. Similarly, the Yersiniae can also invade and replicate inside host cells,
even immune cells. Conversely, Shigella, typically thought of as an intracellular bacterium, can escape
phagocytosis [248].
Central to the pathogenesis of the species discussed in this review, is the T3SS, which leads
to alterations in the cytoskeletal dynamics of target cells, either to promote invasion or to prevent
phagocytosis. This is accomplished by injecting cytoskeletoxic effectors. However, in this review,
we have tried to emphasize that T5SSs also play an essential role in mediating the cytoskeletal changes
brought about by T3SSs effectors in these bacteria. For example, Yop translocation into host cells is
accomplished by docking the T3SS injectisome on the target cell by YadA [232]. The close co-evolution
of YadA and the Ysc T3SS is demonstrated by the correlation in length of the injectisome needle and the
YadA stalk [231]. The intimin–Tir interaction is not only an adhesin–receptor interaction, but represents
an essential step in pedestal formation: the network of intimin–Tir complexes leads to clustering of Tir
and the downstream effects leading to actin polymerisation [146,147]. This is also a direct interaction
between an inverse autotransporter (intimin) on the bacterial surface and an effector protein on the
host cell surface (Tir), demonstrating the tight interplay between the T3SS and T5SS. Both are encoded
on the same pathogenicity island, the LEE, showing how these systems are also coupled on a genetic
level [126]. Similarly, IcsA and YadA are encoded on virulence plasmids together with their respective
T3SSs, showing that these virulence factors have co-evolved [174].
It should be noted that a similarly close connection between the T3SS and T5SS is not universal.
For instance, within the Enterobacterales, a counterexample to the interplay between these two secretion
systems seen in EPEC, Shigella and Yersinia would be Salmonella. Salmonella encodes two T3SSs needed
for host cell invasion and intracellular life [249]. It also produces a several T5SSs [250]. However,
the T5SSs and T3SSs of Salmonella do not have a similarly intimate relationship as in the examples we
have given, and the autotransporters of Salmonella are not required for efficient effector translocation or
T3SS-dependent cell invasion.
Although the cytoskeletoxic effects of the examples above are due to indirect effects of T5SSs, some
T5SSs can themselves have a direct effect on the cytoskeleton of host cells. This is exemplified most
clearly by the autotransporter EspC, which is translocated into host cells by the T3SS to elicit cytoskeletal
changes, among other effects [136]. The fact the EspC is not only translocated by the T3SS but also
plays a role in regulating effector secretion by the T3SS again demonstrates co-evolution between the
two secretion systems [137]. InvA alone is sufficient to induce changes in the actin cortex leading to
uptake of the bacteria, or even InvA-coated beads [220]. Further, YadA can mediate cell invasion by a
similar mechanism [233,234]. IcsA, in addition to promoting effector secretion, also directly interacts
with actin-polymerising proteins to enable intracellular ABM [117,187]. Though of the examples given,
only EspC is a genuine toxin—the other T5SSs covered in this review mediate adverse effects on host
cells through changes in actin dynamics. Examples of T5SSs that interact with actin from outside the
Enterobacterales include BimA, an actin-polymerising TAA from Burkholderia spp. [251,252], and Sca2,
a classical autotransporter that enables ABM in Rickettsia spp [253]. Thus, not only the classical T3SS
effectors but also some T5-secreted proteins could be considered cytoskeletoxins.
The close co-evolution of the T3SS and T5SS in the enteropathogenic Yersiniae, Shigella spp., EPEC
and EHEC is a testament to the versatility and genetic opportunism exhibited by pathogenic bacteria,
and the interplay between the T3SS and T5SS is a fruitful and ongoing area of research.
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